MY183483A - Ophthalmic solution for treating ocular infection comprising levofloxacin or salt thereof or solvate of the same, method for treating ocular infection, levofloxacin or salt thereof or solvate of the same, and use thereof - Google Patents
Ophthalmic solution for treating ocular infection comprising levofloxacin or salt thereof or solvate of the same, method for treating ocular infection, levofloxacin or salt thereof or solvate of the same, and use thereofInfo
- Publication number
- MY183483A MY183483A MYPI2012003769A MYPI2012003769A MY183483A MY 183483 A MY183483 A MY 183483A MY PI2012003769 A MYPI2012003769 A MY PI2012003769A MY PI2012003769 A MYPI2012003769 A MY PI2012003769A MY 183483 A MY183483 A MY 183483A
- Authority
- MY
- Malaysia
- Prior art keywords
- levofloxacin
- ophthalmic solution
- dose regimen
- solvate
- salt
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5383—1,4-Oxazines, e.g. morpholine ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/536—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines ortho- or peri-condensed with carbocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/02—Local antiseptics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Ophthalmology & Optometry (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2010040281 | 2010-02-25 | ||
| PCT/JP2010/072685 WO2011104981A1 (ja) | 2010-02-25 | 2010-12-16 | レボフロキサシンもしくはその塩またはそれらの溶媒和物を含有する眼感染症治療用点眼剤、眼感染症の治療方法、レボフロキサシンもしくはその塩またはそれらの溶媒和物、ならびにその使用 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MY183483A true MY183483A (en) | 2021-02-20 |
Family
ID=44506417
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MYPI2012003769A MY183483A (en) | 2010-02-25 | 2010-12-16 | Ophthalmic solution for treating ocular infection comprising levofloxacin or salt thereof or solvate of the same, method for treating ocular infection, levofloxacin or salt thereof or solvate of the same, and use thereof |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US20120316158A1 (https=) |
| EP (1) | EP2540299B1 (https=) |
| JP (3) | JP5600056B2 (https=) |
| KR (2) | KR20130043611A (https=) |
| CN (1) | CN102770141A (https=) |
| BR (1) | BR112012021247A2 (https=) |
| CA (1) | CA2791190C (https=) |
| EA (1) | EA201290827A1 (https=) |
| ES (1) | ES2568647T3 (https=) |
| MX (1) | MX349603B (https=) |
| MY (1) | MY183483A (https=) |
| NZ (1) | NZ602126A (https=) |
| PH (2) | PH12012501674A1 (https=) |
| SG (1) | SG183427A1 (https=) |
| TW (1) | TWI488627B (https=) |
| WO (1) | WO2011104981A1 (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20130043611A (ko) * | 2010-02-25 | 2013-04-30 | 다이이찌 산쿄 가부시키가이샤 | 레보플록사신 또는 그의 염 또는 그들의 용매화물을 함유하는 안감염증 치료용 점안제, 안감염증의 치료 방법, 레보플록사신 또는 그의 염 또는 그들의 용매화물, 및 그의 용도 |
| CN103550144B (zh) * | 2013-10-25 | 2015-10-14 | 深圳朗欧医药集团有限公司 | 盐酸左氧氟沙星组合物注射液及其制备方法 |
| JP6363833B2 (ja) * | 2013-11-22 | 2018-07-25 | ナノシータ株式会社 | 薄膜状高分子構造体 |
| CN104606198A (zh) * | 2015-01-09 | 2015-05-13 | 周元铎 | 盐酸左氧氟沙星在制备防治家蚕细菌性败血病药中的应用 |
| IT201900005280A1 (it) * | 2019-04-05 | 2020-10-05 | Ntc S R L | Composizione otologica |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3038722B2 (ja) | 1989-06-23 | 2000-05-08 | 日本電気株式会社 | 接合型電界効果トランジスタ |
| JP3192290B2 (ja) | 1993-08-04 | 2001-07-23 | カネボウ株式会社 | ポリエステル製耐熱ボトル |
| US7629458B2 (en) * | 2001-10-03 | 2009-12-08 | Teva Pharmaceutical Industries Ltd. | Preparation of levofloxacin and hemihydrate thereof |
| ES2292844T3 (es) * | 2001-11-30 | 2008-03-16 | Lg Life Sciences Ltd. | Utilizacion de gemifloxacina o sus sales con un antibiotico b-lactamico para la preparacion de medicamentos. |
| US20050009836A1 (en) * | 2003-06-26 | 2005-01-13 | Laskar Paul A. | Ophthalmic composition containing quinolones and method of use |
| WO2005000307A1 (en) * | 2003-06-26 | 2005-01-06 | Santen Pharmaceutical Co., Ltd. | Ophthalmic composition containing quinolones and method of use |
| MX2008010222A (es) * | 2006-02-10 | 2008-10-17 | Pari Pharma Gmbh | Antibioticos nebulizados para terapia de inhalacion. |
| WO2008005276A2 (en) * | 2006-06-30 | 2008-01-10 | Directcontact Llc | Growth factor delivery system containing antimicrobial agents |
| EP2143422A1 (en) * | 2008-07-11 | 2010-01-13 | S.I.F.I - Società Industria Farmaceutica Italiana - S.P.A. | Ophthalmic compositions containing gemifloxacin for the treatment of ocular infections |
| KR20130043611A (ko) * | 2010-02-25 | 2013-04-30 | 다이이찌 산쿄 가부시키가이샤 | 레보플록사신 또는 그의 염 또는 그들의 용매화물을 함유하는 안감염증 치료용 점안제, 안감염증의 치료 방법, 레보플록사신 또는 그의 염 또는 그들의 용매화물, 및 그의 용도 |
-
2010
- 2010-12-16 KR KR1020127024069A patent/KR20130043611A/ko not_active Ceased
- 2010-12-16 CN CN2010800646540A patent/CN102770141A/zh active Pending
- 2010-12-16 EP EP10846644.2A patent/EP2540299B1/en not_active Not-in-force
- 2010-12-16 EA EA201290827A patent/EA201290827A1/ru unknown
- 2010-12-16 MY MYPI2012003769A patent/MY183483A/en unknown
- 2010-12-16 WO PCT/JP2010/072685 patent/WO2011104981A1/ja not_active Ceased
- 2010-12-16 NZ NZ602126A patent/NZ602126A/xx not_active IP Right Cessation
- 2010-12-16 JP JP2010280325A patent/JP5600056B2/ja active Active
- 2010-12-16 KR KR1020177015979A patent/KR20170070265A/ko not_active Ceased
- 2010-12-16 ES ES10846644.2T patent/ES2568647T3/es active Active
- 2010-12-16 MX MX2012009844A patent/MX349603B/es active IP Right Grant
- 2010-12-16 CA CA2791190A patent/CA2791190C/en not_active Expired - Fee Related
- 2010-12-16 BR BR112012021247-8A patent/BR112012021247A2/pt not_active Application Discontinuation
- 2010-12-16 PH PH1/2012/501674A patent/PH12012501674A1/en unknown
- 2010-12-16 US US13/580,931 patent/US20120316158A1/en not_active Abandoned
- 2010-12-16 PH PH1/2016/501747A patent/PH12016501747B1/en unknown
- 2010-12-16 SG SG2012061842A patent/SG183427A1/en unknown
- 2010-12-28 TW TW099146206A patent/TWI488627B/zh not_active IP Right Cessation
-
2012
- 2012-03-12 JP JP2012054761A patent/JP2012162532A/ja active Pending
-
2013
- 2013-08-16 JP JP2013169146A patent/JP5674882B2/ja active Active
Also Published As
| Publication number | Publication date |
|---|---|
| EA201290827A1 (ru) | 2013-03-29 |
| TWI488627B (zh) | 2015-06-21 |
| KR20130043611A (ko) | 2013-04-30 |
| BR112012021247A2 (pt) | 2018-04-03 |
| EP2540299B1 (en) | 2016-04-13 |
| ES2568647T3 (es) | 2016-05-03 |
| SG183427A1 (en) | 2012-09-27 |
| PH12016501747B1 (en) | 2022-06-22 |
| KR20170070265A (ko) | 2017-06-21 |
| JP5600056B2 (ja) | 2014-10-01 |
| TW201129364A (en) | 2011-09-01 |
| CA2791190C (en) | 2017-12-12 |
| JP2011195564A (ja) | 2011-10-06 |
| US20120316158A1 (en) | 2012-12-13 |
| EP2540299A4 (en) | 2013-07-24 |
| JP5674882B2 (ja) | 2015-02-25 |
| JP2012162532A (ja) | 2012-08-30 |
| MX2012009844A (es) | 2012-09-21 |
| PH12016501747A1 (en) | 2019-02-11 |
| AU2010346703A1 (en) | 2012-09-20 |
| NZ602126A (en) | 2013-10-25 |
| HK1177887A1 (en) | 2013-08-30 |
| MX349603B (es) | 2017-08-03 |
| JP2013241464A (ja) | 2013-12-05 |
| EP2540299A1 (en) | 2013-01-02 |
| PH12012501674A1 (en) | 2012-11-05 |
| CA2791190A1 (en) | 2011-09-01 |
| CN102770141A (zh) | 2012-11-07 |
| WO2011104981A1 (ja) | 2011-09-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PH12019502851A1 (en) | New azaquinoline derivatives | |
| PH12020500257A1 (en) | Quinoline derivatives for treating infections with helminths | |
| MX395482B (es) | Compuestos antiproliferativos y metodos de uso de los mismos | |
| NZ713621A (en) | Compounds and methods of treating infections | |
| MX2018005041A (es) | Compuestos para tratar la esclerosis lateral amiotrofica. | |
| PH12016501577B1 (en) | Monobactam organic compounds for the treatment of bacterial infections | |
| MX2017012545A (es) | Compuestos heterociclicos y su uso en la prevencion o tratamiento de las infecciones bacterianas. | |
| MY209256A (en) | Compounds affecting pigment production and use thereof for treatment of bacterial diseases | |
| EA201790726A1 (ru) | Фармацевтическая композиция для лечения язвенного колита | |
| EP3932917A3 (en) | Substituted phenyloxazolidinones for antimicrobial therapy | |
| MX2015012472A (es) | Derivados de manosa para el tratamiento de infecciones bacterianas. | |
| PH12020551117A1 (en) | Compositions for preventing or treating uveitis | |
| MX2019011908A (es) | Macrociclos de peptidos anti-bacterianos y uso de los mismos. | |
| MX2019015007A (es) | Composiciones inmunogénicas que comprenden los polipéptidos derivados de la leucocidina de staphylococcus aureus luka y lukb. | |
| MX2017012535A (es) | Compuestos hetorociclicos novedosos y su uso en la prevencion o tratamiento de las infecciones bacterianas. | |
| GB2541840A (en) | Ophthalmic composition for the treatment of ocular infection | |
| MX2019006768A (es) | Peptidos antimicrobianos. | |
| MY183483A (en) | Ophthalmic solution for treating ocular infection comprising levofloxacin or salt thereof or solvate of the same, method for treating ocular infection, levofloxacin or salt thereof or solvate of the same, and use thereof | |
| MX2017014080A (es) | Compuestos heterociclicos y su uso en la prevencion o tratamiento de las infecciones bacterianas. | |
| MX2022006229A (es) | Composiciones y metodos para el tratamiento de resistencia a la insulina. | |
| MX2017012539A (es) | Compuestos heterociclicos y su uso en la prevencion o tratamiento de las infecciones bacterianas. | |
| PH12020550549A1 (en) | Compositions for preventing or treating lupus | |
| WO2019070709A8 (en) | Compounds for treating or preventing flavivirus infections | |
| PH12020551620A1 (en) | Compositions for preventing or treating dry eye | |
| PH12016502547A1 (en) | Methods for treating infections |